CURELINE MOLECULAR SERVICES (CMS) is a newly established CRO laboratory division of Cureline (www.cureline.com), a global leader in human biospecimen acquisition and analyses. CMS focus is Molecular and Cell Biology services for translational science and precision medicine programs, including manipulations with biofluid cellular fractions and tissue components (cells, DNA, RNA, proteins), comprehensive molecular analyses (proteomics, glycoproteomics, genomics) and cell-based assays. As a part of Cureline Group, CMS also provides access to biospecimen acquisition, translational histopathology, human and animal tissue management and proprietary glycoproteomic technology.

Our team will support your HUMAN SAMPLE VALIDATION STUDIES, including HBS selection for individual projects, custom biobanking, and custom lab protocols transfer. With the FULL SPECTRUM OF SERVICES IN BIOSPECIMEN RESEARCH we will bring a BROAD CLINICAL AND SCIENTIFIC EXPERTISE to your programs:

  • HUMAN BIOSPECIMENS (HBS) – global access, consented and clinically-characterized donors
  • BIOSPECIMEN MOLECULAR ANALYTES: DNA, RNA, Protein lysates – isolation and analyses.

    Link here this page: http://www.cureline.com/human-rna-dna-services.html

  • PRIMARY CELLS (PBMC, BMMC, DTC, stem cells): from blood, bone marrow, lipoaspirates,
    normal and tumor tissues, etc.
  • MOLECULAR AND CELL BIOLOGY: Cell-based assays (cell viability, proliferation, migration,
    invasion, immuno-oncology assays), ELISA
  • TISSUE PROCESSING (human, animal) – preclinical and clinical samples
  • 3D TISSUE CULTURE and assays (including 3D-histoculture)

    Link here this page: http://www.cureline.com/drug-sensitivity-in-3-d-histocultured-tumors.html

  • ANTIBODY characterization and validation
  • BIOMARKER discovery and validation (Proteomics, Genomics, Glycoproteomics)
cms_flyer_03292019finalop
Download our brochure

 

We are looking forward to establishing a connection with your company R&D team, discussing how Cureline Molecular Services could assist your translational research programs, and together accelerating the Patients access to novel medicines and diagnostic tests.

Please contact us at CMSinfo@cureline.com for any further information.